Medical Journal of Australia

1990

DOI: 10.5694/j.1326-5377.1990.tb125127.x

|View full text |Cite

|

Sign up to set email alerts

|

The treatment of psoriasis

Harvey Rotstein

¹

,

Christopher M. Baker

²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Topical Therapy2

Patients With Kidney or Liver Insufficiency1

Citation Types

Supporting

0

Mentioning

3

Contrasting

0

Year Published

1990

1990

2012

2012

Publication Types

Select...

Article7

Relationship

Self Cite0

Independent7

Authors

Journals

Cited by 10 publications

(3 citation statements)

References 179 publications

Supporting

0

Mentioning

3

Contrasting

0

Order By: Relevance

“…Oxidized anthrone, di‐ thranol dimers, and other insoluble polymerization products are excreted by the kidneys. According to Rotstein and Baker, the level of excreted anthralin does not pose a potential risk to the kidneys [115].…”

Section: Topical Therapymentioning

confidence: 99%

S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

¹

,

²

,

³

et al. 2012

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque-type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).

“…Oxidized anthrone, di‐ thranol dimers, and other insoluble polymerization products are excreted by the kidneys. According to Rotstein and Baker, the level of excreted anthralin does not pose a potential risk to the kidneys [115].…”

Section: Topical Therapymentioning

confidence: 99%

S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

¹

,

²

,

³

et al. 2012

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque-type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).

“…According to Rotstein and Baker, the level of excreted anthralin does not pose a potential risk to the kidneys [115]. Oxidized anthrone, dithranol dimers, and other insoluble polymerization products are excreted by the kidneys.…”

Section: Patients With Kidney or Liver Insufficiencymentioning

confidence: 99%

S3 – Guidelines on the treatment of psoriasis vulgaris Update 2011

¹

,

²

,

³

et al. 2011

J Deutsche Derma Gesell

View full text Add to dashboard Cite

No abstract

“…Oxidized anthrone, dithranol dimers and other insoluble polymerization products are excreted through the kidneys. Rotstein and Baker feel that there is no potential renal toxicity from anthralin [73].…”

Section: Topical Therapymentioning

confidence: 99%

Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris

¹

,

²

,

³

et al. 2007

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed lack of satisfaction with the efficacy of available treatments and a high rate of non-compliance. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) initiated a project to develop evidence-based guidelines for the management of psoriasis. These resulting Guidelines focus on induction therapy in cases of mild, moderate, and severe plaquetype psoriasis in adults. The Guidelines include evidence-based evaluation of the efficacy of all currently available therapeutic options in Germany. In addition, they offer detailed information on how best to administer the various treatments and give information on contraindications, adverse drug reactions, and drug interactions as well as estimates of practicability and cost. The Guidelines were developed following the recommendations of the Arbeitsgemeinschaft wissenschaftlicher medizinischer Fachgesellschaften (AWMF). The therapeutic recommendations were developed by an expert group and finalized during interdisciplinary consensus conferences.

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.